Research map: Efficacy of venetoclax combined with azacitidine for advanced blastic plasmacytoid dendritic cell neoplasm: experience from two Japanese cases

Back to the article

Papers in this map

  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms · Joseph David Khoury · 2022 · 4220 citations · Cited by this paper
  2. Two Blastic Plasmacytoid Dendritic Cell Neoplasms treated with the CD123‐targeted agent Tagraxofusp presenting divergent outcomes · Sven C. Engler · 2026 · Cites this paper
  3. Hans’s algorithm and MYD88L265P mutation may affect prognosis of primary central nervous system B-cell lymphoma · 2025 · Related
  4. Clinical experience with the BCL 2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies · Courtney Denton Dinardo · 2017 · 444 citations · Cited by this paper
  5. Real-world comparison of brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone and anthracycline-based regimens in peripheral T-cell lymphoma: A multicenter retrospective study from the Gifu Hematology Study Group · 2026 · Related
  6. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm · Naveen Pemmaraju · 2019 · 437 citations · Cited by this paper
  7. Synchronous diffuse large B-cell lymphoma and gynecological malignancy treated with paclitaxel and carboplatin: A report of two cases · 2026 · Related
  8. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study · Livio Pagano · 2012 · 341 citations · Cited by this paper
  9. Prognostic predictors of newly diagnosed Diffuse large B-cell lymphoma treated with R-THP-COP regimen · 2025 · Related
  10. Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax · Joan Montero · 2016 · 216 citations · Cited by this paper
  11. Adult T-cell leukaemia/lymphoma with different histological features in a single lymph node · 2026 · Related
  12. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia · Francine Garnache‐Ottou · 2009 · 178 citations · Cited by this paper
  13. Rapidly progressive fatal hepatic failure due to IgM-related AL amyloidosis in Waldenström’s macroglobulinemia: an autopsy case report · 2025 · Related
  14. Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile · Lourdes Martín‐Martín · 2015 · 123 citations · Cited by this paper
  15. A therapeutic effect of Forodesine for CNS relapsed primary testicular T cell lymphoma after allogeneic transplantation · 2025 · Related
  16. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response · Kana Sakamoto · 2018 · 89 citations · Cited by this paper
  17. Initial disease presentation with myelomatous pleural effusion is an ominous sign for multiple myeloma: report of a case emphasizing cytological features and ancillary studies · 2025 · Related
  18. Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm · Naveen Pemmaraju · 2022 · 76 citations · Cited by this paper
  19. Advances in clonality analysis of human T-cell leukemia virus type 1-infected cells: from Southern blotting to high-throughput sequencing · 2025 · Related
  20. Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant · Seongseok Yun · 2020 · 52 citations · Cited by this paper
  21. Blastic Plasmacytoid Dendritic Cell Neoplasm · Akriti Gupta Jain · 2023 · 44 citations · Cited by this paper
  22. Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm · Naseema Gangat · 2021 · 41 citations · Cited by this paper
  23. Novel treatment of blastic plasmacytoid dendritic cell neoplasm · Solomiya Grushchak · 2017 · 34 citations · Cited by this paper
  24. Blastic plasmacytoid dendritic cell neoplasm ( BPDCN ): A promising future in the era of targeted therapeutics · Ijele Adimora · 2022 · 26 citations · Cited by this paper
  25. Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm · Minas Platon Economides · 2019 · 21 citations · Cited by this paper
  26. Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia · Jingying Cui · 2023 · 20 citations · Cited by this paper
  27. Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature · Nil Albiol · 2021 · 16 citations · Cited by this paper
  28. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review · Yemin Wang · 2023 · 13 citations · Cited by this paper
  29. Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm · Yumeng Zhang · 2022 · 11 citations · Cited by this paper
  30. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations · Evgenii Shumilov · 2024 · 9 citations · Cited by this paper
  31. Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm · Matthew Schwede · 2020 · 7 citations · Cited by this paper
  32. Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm · Ronan Le Calloch · 2022 · 7 citations · Cited by this paper
  33. The distinctive cytology and disease evolution of blastic plasmacytoid dendritic cell neoplasm · Filipa Ramalho Fernandes · 2018 · 6 citations · Cited by this paper
  34. Venetoclax and Azacitidine in the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory to Conventional Therapy · Farhan Azad · 2022 · 6 citations · Cited by this paper
  35. Ven the dose matters: Venetoclax dosing in the frontline treatment of AML · Dahniel L. Sastow · 2024 · 6 citations · Cited by this paper
  36. Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding · Kana Sakamoto · 2025 · 5 citations · Cited by this paper
  37. Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment · Xiaoning Wang · 2024 · 5 citations · Cited by this paper
  38. Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN · Naveen Pemmaraju · 2025 · 5 citations · Cited by this paper
  39. Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm · Yasuhiro Nagate · 2023 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)